
Overview
Rajshekhar Chakraborty, MD is an assistant professor of medicine at Columbia University Irving Medical Center in the division of hematology/oncology. After receiving his medical degree from University of Delhi, India, he completed his residency in internal medicine at Icahn School of Medicine at Mount Sinai-Queens Hospital Center. Subsequently, he spent three years as a clinical researcher in plasma cell disorders at the Mayo Clinic, Rochester, followed by fellowship in hematology/oncology at the Cleveland Clinic.During fellowship, he conducted outcomes research with a focus on quality of life and treatment-related toxicities in plasma cell disorders. After fellowship, he started his job as Assistant Professor of Medicine at the Multiple Myeloma and Amyloidosis Program at Columbia University Irving Medical Center.Dr. Chakraborty cares primarily for patients with plasma cells disorders, including multiple myeloma, amyloidosis, MGUS, POEMS syndrome, and Waldenstrom’s macroglobulinemia. His research interests include clinical trials and outcomes research in plasma cell disorders.
Dr. Chakraborty is highly rated in 12 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Smoldering Multiple Myeloma, Bone Marrow Transplant, and Colonoscopy.
His clinical research consists of co-authoring 165 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
161 Fort Washington Avenue, New York, NY 10032
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Alison Moskowitz is a Hematologist and an Oncologist in New York, New York. Dr. Moskowitz is highly rated in 33 conditions, according to our data. Her top areas of expertise are T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Steven Horwitz is a Hematologist and an Oncologist in New York, New York. Dr. Horwitz is highly rated in 26 conditions, according to our data. His top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Horwitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Gilles Salles is a Hematologist and an Oncologist in New York, New York. Dr. Salles is highly rated in 27 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Bone Marrow Transplant, and Splenectomy. Dr. Salles is currently accepting new patients.
Frequently Asked Questions about Dr. Rajshekhar Chakraborty
How do I make an appointment with Dr. Rajshekhar Chakraborty?
You can book an appointment with Dr. Rajshekhar Chakraborty by calling their office at 212-305-5098. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Rajshekhar Chakraborty a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rajshekhar Chakraborty is classified as an Elite expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Rajshekhar Chakraborty specialize in?
While Dr. Rajshekhar Chakraborty is a Oncology, they have specific expertise in Multiple Myeloma, Primary Amyloidosis, and Smoldering Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Rajshekhar Chakraborty participate in research or clinical trials?
Yes. Dr. Rajshekhar Chakraborty has published 165 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Rajshekhar Chakraborty's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Rajshekhar Chakraborty accept my insurance?
Dr. Rajshekhar Chakraborty accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-305-5098 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Multiple MyelomaDr. Chakraborty isElite. Learn about Multiple Myeloma.
- Distinguished
- Primary AmyloidosisDr. Chakraborty isDistinguished. Learn about Primary Amyloidosis.
- Relapsed Refractory Multiple Myeloma (RRMM)Dr. Chakraborty isDistinguished. Learn about Relapsed Refractory Multiple Myeloma (RRMM).
- Smoldering Multiple MyelomaDr. Chakraborty isDistinguished. Learn about Smoldering Multiple Myeloma.
- Advanced
- Bone Marrow TransplantDr. Chakraborty isAdvanced. Learn about Bone Marrow Transplant.
- Cardiac AmyloidosisDr. Chakraborty isAdvanced. Learn about Cardiac Amyloidosis.
- Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
- GTP Cyclohydrolase 1 DeficiencyDr. Chakraborty isAdvanced. Learn about GTP Cyclohydrolase 1 Deficiency.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Pseudocholinesterase DeficiencyDr. Chakraborty isAdvanced. Learn about Pseudocholinesterase Deficiency.
- Experienced
- Cerebral Amyloid AngiopathyDr. Chakraborty isExperienced. Learn about Cerebral Amyloid Angiopathy.
- ColonoscopyDr. Chakraborty isExperienced. Learn about Colonoscopy.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Chakraborty isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Hereditary Cerebral Amyloid AngiopathyDr. Chakraborty isExperienced. Learn about Hereditary Cerebral Amyloid Angiopathy.
- Large-Cell Immunoblastic LymphomaDr. Chakraborty isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- Myelodysplastic Syndrome (MDS)Dr. Chakraborty isExperienced. Learn about Myelodysplastic Syndrome (MDS).
